Inositol hexaniacinate

Inositol nicotinate/Drug Interactions:

  • AlcoholAlcohol: According to secondary sources, inositol nicotinate should not be taken with alcohol, as increases in flushing may occur.
  • Anticoagulants and antiplatelet agentsAnticoagulants and antiplatelet agents: In human research, Hexopal? was reported to enhance fibrinolysis (1). Based on anecdotal evidence, inositol nicotinate may increase the risk of bleeding.
  • Antidiabetic agentsAntidiabetic agents: According to secondary sources, increases in blood sugar may occur.
  • AntihypertensivesAntihypertensives: The antihypertensive effects of inositol nicotinate have been examined in human research that was also investigating other antihypertensive agents; however, the effects of inositol nicotinate were unclear (6).
  • Antilipemic agentsAntilipemic agents: Based on human evidence, inositol nicotinate may have cholesterol-lowering effects (2; 1).
  • CarbamazepineCarbamazepine: According to secondary sources, inositol nicotinate should not be combined with carbamazepine.
  • Cardiovascular agentsCardiovascular agents: In human research, inositol nicotinate improved symptoms associated with intermittent claudication (3; 4).
  • NicotineNicotine: According to secondary sources, smoking may produce additional narrowing of blood vessels.
  • VasodilatorsVasodilators: Based on a human study, inositol nicotinate may have vasodilating effects (1).

    • Inositol nicotinate/Herb/Supplement Interactions:

  • Anticoagulants and antiplatelet agentsAnticoagulants and antiplatelet agents: In human research, Hexopal? was reported to enhance fibrinolysis (1). Based on anecdotal evidence, inositol nicotinate may increase the risk of bleeding.
  • AntilipemicsAntilipemics: Based on human evidence, inositol nicotinate may have cholesterol-lowering effects (2; 1).
  • Cardiovascular herbs and supplementsCardiovascular herbs and supplements: In human research, inositol nicotinate improved symptoms associated with intermittent claudication (3; 4).
  • HypoglycemicsHypoglycemics: According to secondary sources, increases in blood sugar may occur.
  • HypotensivesHypotensives: The antihypertensive effects of inositol nicotinate have been examined in human research that was also investigating other antihypertensive agents; however, the effects of inositol nicotinate were unclear (6).
  • NicotineNicotine: According to secondary sources, smoking may produce additional narrowing of blood vessels.
  • Vasodilator herbs and supplementsVasodilator herbs and supplements: Based on human research, inositol nicotinate may have vasodilating effects (1).

    • Inositol nicotinate/Food Interactions:

  • Insufficient available evidence.

    • Inositol nicotinate/Lab Interactions:

  • Blood pressureBlood pressure: The antihypertensive effects of inositol nicotinate have been examined in a study also investigating other antihypertensive agents, but the effects of inositol nicotinate were unclear (6).
  • Coagulation panelCoagulation panel: In human research, Hexopal? was reported to enhance fibrinolysis (1). Based on anecdotal evidence, inositol nicotinate may increase the risk of bleeding.
  • GlucoseGlucose: According to secondary sources, increases in blood sugar may occur.
  • Lipid panelLipid panel: Based on human evidence, inositol nicotinate may have cholesterol-lowering effects (2; 1).